ArticleOncoimmunology
Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer.
Sonia Domingos-Pereira et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
cites it